In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and bringing about improvement in motor function.

With over 1.7 million people in Scotland being affected by MSK conditions, the physio-approved guidance is available at the ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

The Memorial Sloan Kettering High Performance Computing Group is home to powerful advanced computing systems designed to facilitate and satisfy the needs of MSK and SKI research.